Patients who developed hypertension with Avastin® (bevacizumab) had better response to treatment for colorectal cancer. More had tumors shrink, and it took significantly longer for their cancer to get worse.
In a small Italian study, researchers measured blood pressure in 39 patients receiving Avastin along with irinotecan and 5-FU for the initial treatment of colorectal cancer. Eight patients (20 percent) experienced grade 2 or 3 hypertension. Read the rest of this entry »



